| Structure |
Chemical Name |
CAS |
MF |
 |
Bupropion |
34911-55-2 |
C13H18ClNO |
 |
6-THIO-2'-DEOXYGUANOSINE |
789-61-7 |
C10H13N5O3S |
 |
Linaprazan |
248919-64-4 |
C21H26N4O2 |
 |
CHLORPHENOXAMINE |
77-38-3 |
C18H22ClNO |
 |
CYCLO(-ARG-GLY-ASP-D-TYR-LYS) |
217099-14-4 |
C27H41N9O8 |
 |
2,3,4-TRIMETHOXYBENZYL ALCOHOL |
71989-96-3 |
C10H14O4 |
![GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide](/CAS/GIF/660868-91-7.gif) |
GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide |
660868-91-7 |
C22H18F3N3O4S |
 |
Atrasentan hydrochloride |
195733-43-8 |
C29H38N2O6.ClH |
 |
Talaporfin sodium |
220201-34-3 |
C38H42N5NaO9 |
 |
4-Methylpyrazole |
7554-65-6 |
C4H6N2 |
 |
Zacopride hydrochloride |
101303-98-4 |
C15H21Cl2N3O2 |
 |
CP-547632 |
252003-65-9 |
C20H24BrF2N5O3S |
![1-(4-Fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1,2-dihydro-2-oxo-3-pyridinecarboxamide](/CAS2/GIF/888719-03-7.gif) |
1-(4-Fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1,2-dihydro-2-oxo-3-pyridinecarboxamide |
888719-03-7 |
C25H16F2N4O3 |
![3-[3-[2-(1-Piperidinyl)ethoxy]phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole](/CAS2/GIF/395104-30-0.gif) |
3-[3-[2-(1-Piperidinyl)ethoxy]phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole |
395104-30-0 |
C22H24N6O |
![N-[2,4-Difluoro-3-[[5-(3-pyridinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]phenyl]-2-propanesulfonamide](/CAS/20180906/GIF/918505-61-0.gif) |
N-[2,4-Difluoro-3-[[5-(3-pyridinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]phenyl]-2-propanesulfonamide |
918505-61-0 |
C22H18F2N4O3S |
 |
Nsc66811 |
6964-62-1 |
C23H20N2O |
 |
VCH-916 |
1200133-34-1 |
C26H36KNO4S |
 |
GW791343 dihydrochloride |
1019779-04-4 |
C20H24F2N4O |
 |
Vaniprevir |
923590-37-8 |
C38H55N5O9S |
 |
1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol |
147591-46-6 |
C16H14N2O4 |
 |
Losartan-d4 Carboxylic Acid |
1246820-62-1 |
C22H21ClN6O2 |
 |
Delamanid |
681492-22-8 |
C25H25F3N4O6 |
 |
MK-8998 |
953778-58-0 |
C20H23F3N2O2 |
 |
Amg 517 |
659730-32-2 |
C20H13F3N4O2S |
 |
AC-55541 |
916170-19-9 |
C25H20BrN5O3 |
 |
Unii-950o97nupo |
377727-87-2 |
C25H29N9O3 |
![N-[trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-4-quinolinecarboxamide](/CAS/GIF/215803-78-4.gif) |
N-[trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-4-quinolinecarboxamide |
215803-78-4 |
C28H30N4O |
 |
BML-210 |
537034-17-6 |
C20H25N3O2 |
 |
FIPI |
939055-18-2 |
C23H24FN5O2 |
![2-Amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)-3-pyridinecarbonitrile hydrochloride](/CAS/20200401/GIF/406209-26-5.gif) |
2-Amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)-3-pyridinecarbonitrile hydrochloride |
406209-26-5 |
C21H25ClN4O2 |
 |
SCH-900776 |
891494-64-7 |
C15H18BrN7 |
 |
AnaMorelin hydrochloride |
861998-00-7 |
C31H43ClN6O3 |
 |
BN-2629 |
232931-57-6 |
C31H32N4O6 |
 |
ARRY-520 |
885060-09-3 |
C20H22F2N4O2S |
 |
KN-92 (hydrochloride) |
1431698-47-3 |
C24H26Cl2N2O3S |
 |
PSN632408 |
857652-30-3 |
C18H24N4O4 |
 |
CEP-32496 |
1227678-26-3 |
C24H23ClF3N5O5 |
 |
A 804598 |
1125758-85-1 |
C19H17N5 |
 |
NDT 9513727 |
439571-48-9 |
C36H35N3O4 |
 |
(E)-1-(3-chloro-4-fluorophenyl)-4-((5-nitrofuran-2-yl)Methylene)pyrazolidine-3,5-dione |
423148-78-1 |
C14H7ClFN3O5 |
 |
GAP 27 |
198284-64-9 |
C60H101N15O17 |
 |
AST-1306 |
897383-62-9 |
C24H18ClFN4O2 |
 |
GSK-25 |
874119-56-9 |
C24H16Cl2F2N6O |
 |
1alpha, 24, 25-Trihydroxy VD2 |
457048-34-9 |
C28H44O4 |
 |
BAY 61-3606 (dihydrochloride) |
648903-57-5 |
C20H20Cl2N6O3 |
 |
BIX02189 |
1265916-41-3 |
C27H28N4O2 |
 |
PDK1 inhibitor |
1001409-50-2 |
C28H22F2N4O4 |
 |
Belumosudil |
911417-87-3 |
C26H24N6O2 |
![5-PyriMidinecarboxaMide, 2-[[2-(3-chloro-4-hydroxyphenyl)ethyl]aMino]-4-[(phenylMethyl)aMino]-](/CAS/GIF/919486-40-1.gif) |
5-PyriMidinecarboxaMide, 2-[[2-(3-chloro-4-hydroxyphenyl)ethyl]aMino]-4-[(phenylMethyl)aMino]- |
919486-40-1 |
C20H20ClN5O2 |
 |
BAY-57-1293 |
348086-71-5 |
C18H18N4O3S2 |
 |
BenzenesulfonaMide, 5-(phenylsulfonyl)-N-4-piperidinyl-2-(trifluoroMethyl)- |
915759-45-4 |
C18H19F3N2O4S2 |
 |
ELN 441958 |
913064-47-8 |
C29H29ClN4O2 |
 |
GeMigliptin |
911637-19-9 |
C18H19F8N5O2 |
 |
GLI1-Mediated transcription inhibitor |
496794-70-8 |
C24H23ClN4O3 |
 |
LOR 253 |
916151-99-0 |
C22H14FN5 |
 |
MibaMpator |
375345-95-2 |
C21H30N2O4S2 |
 |
N3PT |
13860-66-7 |
C13H19Cl2N3OS |
 |
Opicapone |
923287-50-7 |
C15H10Cl2N4O6 |
 |
PPQ-102 |
931706-15-9 |
C26H22N4O3 |
 |
Repertaxin |
266359-83-5 |
C14H21NO3S |
 |
XL647 |
781613-23-8 |
C24H25Cl2FN4O2 |
 |
PF 04447943 |
1082744-20-4 |
C20H25N7O2 |
 |
Hederagenin 3-O-α-L-rhaMnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4))-α-L-arabinopyranoside |
68027-15-6 |
C47H76O17 |
 |
L 2-401 |
883050-24-6 |
C16H13FN2O2S |
 |
Roniciclib |
1223498-69-8 |
C18H21F3N4O3S |
![(2S)-Methyl 2-(2-chlorophenyl)-2-(2-oxo-7,7a-dihydrothieno[3,2-c]pyridin-5(2H,4H,6H)-yl)acetate](/CAS/20150408/GIF/1147350-75-1.gif) |
(2S)-Methyl 2-(2-chlorophenyl)-2-(2-oxo-7,7a-dihydrothieno[3,2-c]pyridin-5(2H,4H,6H)-yl)acetate |
1147350-75-1 |
C16H16ClNO3S |
 |
AT 7867 dihydrochloride |
1431697-86-7 |
C20H21Cl2N3 |
 |
CC401 HCl |
1438391-30-0 |
C22H25ClN6O |
 |
c-Met inhibitor 1 |
1357072-61-7 |
C17H14N8S |
 |
XR9576 |
625375-83-9 |
C39H42N4O9S |
 |
QNZ-46 |
1237744-13-6 |
C24H17N3O6 |
 |
LH-846 |
639052-78-1 |
C16H13ClN2OS |
 |
PF 4618433 |
1166393-85-6 |
C24H27N7O2 |
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]aMino]-](/CAS/20150408/GIF/1232030-35-1.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]aMino]- |
1232030-35-1 |
C25H23Cl2FN6O |
 |
LY 2606368 |
1234015-52-1 |
C18H19N7O2 |
 |
ADH 1 |
229971-81-7 |
C22H34N8O6S2 |
 |
LY2334737 |
892128-60-8 |
C17H25F2N3O5 |
 |
ML281 |
1404437-62-2 |
C22H19N3O2S |
 |
O-Propargyl-PuroMycin |
1416561-90-4 |
C24H29N7O5 |
 |
20-O-Acetylingenol-3-angelate |
82425-35-2 |
C27H36O7 |
 |
AICAR (phosphate) |
681006-28-0 |
C9H17N4O9P |
 |
LHW090-A7 |
1308256-94-1 |
C20H22ClNO4 |
 |
ZLN005 |
49671-76-3 |
C17H18N2 |
 |
AdipoRon |
924416-43-3 |
C27H28N2O3 |
 |
LEE011 (hydrochloride) |
1211443-80-9 |
C23H31ClN8O |
 |
ML314 |
1448895-09-7 |
C24H28N4O3 |
 |
Emixustat hydrochloride |
1141934-97-5 |
C16H26ClNO2 |
![1-tert-butyl-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine hydrochloride](/CAS/20150408/GIF/956025-47-1.gif) |
1-tert-butyl-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine hydrochloride |
956025-47-1 |
C19H20ClN5 |
 |
Atglistatin |
1469924-27-3 |
C17H21N3O |
 |
PCI-32765 (RaceMate) |
936563-87-0 |
C25H24N6O2 |
 |
GNE-7915 (tosylate) |
2070015-00-6 |
C26H29F4N5O6S |
 |
4EGI-1 |
315706-13-9 |
C18H12Cl2N4O4S |
 |
2-AMino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester |
305834-79-1 |
C17H17ClN2O5 |
 |
Thiazolidine-4-carboxylic acid |
444-27-9 |
C4H7NO2S |
 |
RO5126766(CH5126766) |
946128-88-7 |
C21H18FN5O5S |
 |
I-CBP112 |
1640282-31-0 |
C27H36N2O5 |
 |
IWP-3 |
687561-60-0 |
C22H17FN4O2S3 |
 |
Cerdulatinib |
1198300-79-6 |
C20H27N7O3S |
 |
HG-14-10-04 |
1356962-34-9 |
C29H34ClN7O |
 |
kb-NB77-78 |
1350622-33-1 |
C18H25NO3Si |